Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population

Int J Hematol. 2022 Mar;115(3):440-445. doi: 10.1007/s12185-021-03242-3. Epub 2021 Oct 29.

Abstract

A 43-year-old Japanese male, who had undergone open liver surgery for tumor resection, presented with decreased hemoglobin levels on Day 13 post-emergency-release transfusion of 16 units of Fy(a +) red blood cells. As the anemia was accompanied by increased lactate dehydrogenase, indirect bilirubin, and reticulocytes, as well as decreased haptoglobin, it was attributed to hemolysis. In the diagnostic workup for hemolytic reaction, the direct antiglobulin test result for IgG was positive and the antibody dissociated from the patient's peripheral red blood cells was identified as anti-Fya (titer, 4). The hemolytic reaction was transient (approximately 10 days), of moderate severity, and did not result in any obvious organ damage. However, a single compatible red blood cell transfusion of 2 units was required on Day 17 after the causative transfusion. Notably, HLA typing revealed that the patient carried the HLA-DRB1*04:03 allele, which has been implicated in immunogenicity and induction of anti-Fya response in Caucasian populations. In summary, this is the first documented case of definitive anti-Fya-mediated delayed hemolytic transfusion reaction associated with HLA-DRB1*04:03 in the Japanese population.

Keywords: Delayed hemolytic transfusion reaction; Human leukocyte antigen; Irregular antibody; Red blood cell transfusion.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alleles
  • Asian People
  • Blood Group Incompatibility / etiology*
  • Blood Group Incompatibility / genetics*
  • Blood Group Incompatibility / immunology
  • Duffy Blood-Group System / genetics*
  • Emergencies
  • Erythrocyte Transfusion / adverse effects*
  • Erythrocyte Transfusion / methods*
  • HLA-DRB1 Chains / genetics*
  • Hemolysis*
  • Humans
  • Male
  • Patient Acuity
  • Phenotype
  • Time Factors
  • Transfusion Reaction / etiology*
  • Transfusion Reaction / genetics*
  • Transfusion Reaction / immunology

Substances

  • Duffy Blood-Group System
  • HLA-DRB1 Chains
  • HLA-DRB1*04 antigen